MannKind Corporation

NASDAQ:MNKD

Biotechnology

Healthcare
$3.95 -0.51%

-$0.02 today

Market cap
$1.27B
Beta
1.11
P/E (TTM)
-50.3
EPS (TTM)
-$0.08
52W Low $2.23High $6.51

Volume 4.08M

Average 5.73M

Income Statement

Follow revenue through to earnings.

Revenue

$348.97M

FY 2025 · Annual

+22.2% YoY

Operating Income

$38.80M

FY 2025 · Annual

-46.5% YoY

Net Income

$5.86M

FY 2025 · Annual

-78.7% YoY

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue75.44M99.77M198.96M285.5M348.97M
Cost of Revenue38.86M57.5M62.77M76.6M61.16M
Gross Profit36.59M42.27M136.19M208.9M287.81M
Gross Margin48.5%42.4%68.5%73.2%82.5%
Research & Development12.31M19.72M31.28M45.89M66.35M
Selling, General & Admin77.42M91.47M94.31M94.33M144.14M
Operating Expenses83.61M106.38M127.51M136.32M249.01M
Depreciation & Amortization3.24M6.31M4.54M8.97M12.28M
EBITDA(61.11M)(56.32M)15.13M77.47M27.52M
EBITDA Margin-81.0%-56.4%7.6%27.1%7.9%
Operating Income(47.02M)(64.11M)8.68M72.59M38.8M
Operating Margin-62.3%-64.3%4.4%25.4%11.1%
Interest Income112K2.51M6.15M12.62M0
Interest Expense16.58M24.77M25.16M37.98M13.83M
Other Income / Expenses(33.9M)(23.29M)(19.06M)(42.07M)(37.39M)
Income Before Tax(80.93M)(87.4M)(10.38M)30.52M1.41M
Pre-Tax Margin-107.3%-87.6%-5.2%10.7%0.4%
Income Tax Expense001.56M2.93M(4.46M)
Net Income(80.93M)(87.4M)(11.94M)27.59M5.86M
Net Margin-107.3%-87.6%-6.0%9.7%1.7%
EPS (Basic)(0.37)(0.44)(0.04)0.100.02
EPS (Diluted)(0.37)(0.44)(0.04)0.100.02
Weighted Avg Shares249.24M257.09M267.01M274.42M305.64M
Weighted Avg Shares (Diluted)249.24M257.09M267.01M283.84M314.11M

MNKD Earnings Waterfall · TTM

NASDAQ:MNKD · Revenue to Net Income

Key Ratios

EPS$-0.08
Gross Margin75.7%
Net Margin-5.5%
P/E Ratio110.0
P/S Ratio14.7

Analysis

$360.8M of revenue converted into -$23.9M of net income for the selected period. Gross margin is 75.7% and net margin is -5.5%, showing how much revenue survives after costs and taxes. EPS is $-0.08, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipSep 28, 2026
4Statement of changes in beneficial ownershipSep 14, 2026

How much revenue does MNKD generate?

MannKind Corporation (MNKD) reported $348.97M of revenue in fiscal 2025.

Is MNKD profitable?

MannKind Corporation (MNKD) reported $5.86M of net income, with a net margin of 1.7%.